peer-reviewed research papers published since 2017
h-index score of our Founder and CEO, Eric Schadt, Ph.D.
PhDs and MDs currently employed at Sema4
large next generation sequencing (NGS) panels run
Sema4’s Founder and CEO, Eric Schadt, Ph.D., is a world-renowned expert on constructing predictive models of disease that link molecular biology to physiology to enable clinical medicine. He has published more than 450 peer-reviewed papers in leading journals, with a publication citation or “h-” index of 132. In addition, Dr. Schadt has contributed to discoveries relating to the genetic basis of common human diseases, such as cancer, diabetes, obesity, and Alzheimer’s disease, and received many awards, including the Thomson Reuters World’s Most Influential Scientific Minds Award.
Our research team, led by Dr. Schadt, includes world leaders in data science, machine learning, network modeling, and genomics. We currently employ more than 160 Ph.D.-level scientists, in addition to physician-scientists and certified technicians. Our ongoing collaborations with scientists and clinicians in the Mount Sinai and other healthcare systems allow Sema4’s research to remain patient-centered and clinically relevant.
As a research partner, Sema4 can support a range of studies, from optimizing biomarker discovery to leveraging our biorepository services and accelerating clinical trial enrollment. We can bring a range of capabilities to partnerships, including:
We currently partner with numerous pharmaceutical companies, major health systems, research consortia, clinicians, and advocacy groups.